LabGenomics Co Ltd
084650
Company Profile
Business description
LabGenomics Co Ltd is a healthcare company. The Company operates in three business divisions namely NGS, Diagnostic service, IVD products. NGS offers mom guard, cancer panel, Predisposition panel and PGS; Diagnostic service provides esoteric tests such as cancer genetics, genetic disorder. Whereas IVD products include DNA chips, PCR kit among others.
Contact
700 Daewangpangyo-ro
6F-B, Bundang-gu
Korea Bio Park Building
Gyeonggi-do
Seongnam463-400
KORT: +82 316280702
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
158
Stocks News & Analysis
stocks
Is this the catalyst US tech giant needs?
Muse models may just be the spark that the rirm needed in AI model development.
stocks
ASX share plunges due to Iran related weakness
Despite headwinds our long-term outlook is unchanged.
stocks
Investors punish this ASX player after acquisition
We think the floundering stock price is not reflective of underlying asset value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,093.40 | 13.60 | -0.15% |
| CAC 40 | 8,259.60 | 13.81 | 0.17% |
| DAX 40 | 23,803.95 | 3.04 | -0.01% |
| Dow JONES (US) | 47,916.57 | 269.23 | -0.56% |
| FTSE 100 | 10,600.53 | 2.95 | -0.03% |
| HKSE | 25,587.26 | 306.28 | -1.18% |
| NASDAQ | 22,902.89 | 80.48 | 0.35% |
| Nikkei 225 | 56,282.79 | 641.32 | -1.13% |
| NZX 50 Index | 12,989.56 | 191.88 | -1.46% |
| S&P 500 | 6,816.89 | 7.77 | -0.11% |
| S&P/ASX 200 | 8,907.00 | 4.80 | -0.05% |
| SSE Composite Index | 3,979.26 | 6.96 | -0.17% |